Published in Ophthalmology on February 01, 1992
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). Ocul Surf (2012) 1.08
Femtosecond laser-assisted selective reduction of neovascularization in rat cornea. Lasers Med Sci (2014) 0.79
Laser treatment of corneal vessels. Ophthalmology (1992) 0.75
Role of Frequency Doubled Nd: Yag Laser in Treatment of Corneal Neovascularisation. J Clin Diagn Res (2016) 0.75
Management of High-risk Corneal Transplantation. Surv Ophthalmol (2016) 0.75
Scleritis-associated uveitis. Ophthalmology (1997) 7.34
Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology (1992) 6.62
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene (2007) 4.81
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol (2000) 4.70
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene (2006) 3.09
Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol (1996) 3.04
Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer (2006) 2.76
Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene (2007) 2.68
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer (2010) 2.45
Severity of scleritis and episcleritis. Ophthalmology (1994) 2.43
Anterior chamber crystals following hyphema. Arch Ophthalmol (1990) 2.39
Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma. Ophthalmology (1999) 2.33
Infectious endophthalmitis. Review of 36 cases. Ophthalmology (1982) 2.26
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br J Cancer (2012) 2.15
Cicatricial pemphigoid. Trans Am Ophthalmol Soc (1986) 2.10
Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res (2000) 1.99
Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Ophthalmology (1995) 1.98
Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol (2002) 1.91
Mitomycin eye drops as treatment for pterygium. Ophthalmology (1988) 1.89
Immunomodulatory therapy for chronic tubulointerstitial nephritis-associated uveitis. Am J Ophthalmol (2000) 1.84
The characteristic features of optical coherence tomography in posterior uveitis. Br J Ophthalmol (2007) 1.78
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study. Br J Cancer (2009) 1.77
Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial. Am J Ophthalmol (1997) 1.71
Monoclonal antibodies to the human mammary gland. I. Distribution of determinants in non-neoplastic mammary and extra mammary tissues. Virchows Arch A Pathol Anat Histol (1982) 1.68
Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea (1991) 1.65
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. Br J Cancer (2008) 1.62
Schirmer test after topical anesthesia and the tear meniscus height in normal eyes. Arch Ophthalmol (1979) 1.62
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60
Posterior capsule opacification after cataract surgery in patients with uveitis. Ophthalmology (1997) 1.59
Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology (1999) 1.57
An analysis of therapeutic decision for scleritis. Ophthalmology (1993) 1.55
Wegener's granulomatosis: the relationship between ocular and systemic disease. J Rheumatol (2001) 1.55
The value of combined serum angiotensin-converting enzyme and gallium scan in diagnosing ocular sarcoidosis. Ophthalmology (1995) 1.54
Ocular features associated with anticardiolipin antibodies: a descriptive study. Am J Ophthalmol (2001) 1.53
Ocular syphilis. Ophthalmology (1990) 1.53
Ocular Whipple's disease: earlier definitive diagnosis. Ophthalmology (2001) 1.50
Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid. Ophthalmology (1995) 1.48
Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology (1984) 1.46
An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea (1990) 1.46
Ocular rosacea: patient characteristics and follow-up. Ophthalmology (1997) 1.43
Long-term follow-up study of mitomycin eye drops as adjunctive treatment of pterygia and its comparison with conjunctival autograft transplantation. Cornea (1990) 1.40
Molecular basis of disease processes. Hum Pathol (2001) 1.39
Fibronectin in healing rabbit corneal wounds. Lab Invest (1981) 1.37
Immunosuppressive therapy for external ocular inflammatory disease. Ophthalmology (1980) 1.35
Comparison of mechanical properties of keratoconus and normal corneas. Exp Eye Res (1982) 1.34
Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology (1999) 1.34
Factors influencing predilection and outcome in bacterial keratitis. Cornea (1989) 1.33
Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol (2001) 1.30
The brown bowel syndrome: a possible smooth muscle mitochondrial myopathy? Histopathology (1979) 1.30
Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology (1997) 1.30
Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients. Prostate Cancer Prostatic Dis (2007) 1.29
Differential expression of voltage-activated Na+ currents in two prostatic tumour cell lines: contribution to invasiveness in vitro. FEBS Lett (1995) 1.27
Immunopathology of scleritis. Ophthalmology (1991) 1.27
Intermediate uveitis and retinal vasculitis as manifestations of cat scratch disease. Am J Ophthalmol (1996) 1.25
Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management. Cornea (1995) 1.25
Changing patterns in uveitis of childhood. Ophthalmology (1996) 1.24
Monoclonal antibodies and human tumor pathology. Hum Pathol (1982) 1.24
Concepts of epigenetics in prostate cancer development. Br J Cancer (2008) 1.24
Squamous cell carcinoma of the conjunctiva. Int Ophthalmol Clin (1997) 1.24
Miconazole therapy for keratomycosis. Am J Ophthalmol (1981) 1.24
bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol (1996) 1.23
A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic Dis (2005) 1.22
Sarcoidosis and its ocular manifestations. Int Ophthalmol Clin (1996) 1.22
Scleritis associated with systemic vasculitic diseases. Ophthalmology (1995) 1.22
Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology (2001) 1.21
Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer. Am J Pathol (1999) 1.20
Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology (1982) 1.19
Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells. FEBS Lett (1998) 1.18
Basement membrane components in healing rabbit corneal epithelial wounds: immunofluorescence and ultrastructural studies. J Cell Biol (1984) 1.17
Gas-permeable scleral contact lens therapy in ocular surface disease. Am J Ophthalmol (2000) 1.17
Six cases of scleritis associated with systemic infection. Am J Ophthalmol (1992) 1.16
Amniotic membrane surgery. Curr Opin Ophthalmol (2001) 1.15
Collagen crosslinking in keratoconus. Invest Ophthalmol Vis Sci (1978) 1.15
Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol (1999) 1.15
Penetrating keratoplasty in cicatrizing conjunctival diseases. Ophthalmology (1995) 1.15
Improved detection of disease progression in ocular cicatricial pemphigoid. Cornea (1992) 1.14
Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. Ophthalmology (1994) 1.13
Penetrating keratoplasty for herpes simplex keratitis. Am J Ophthalmol (1981) 1.13
Immunohistopathologic features and therapy of conjunctival lichen planus. Am J Ophthalmol (1993) 1.13
Corneal infection in mucosal scarring disorders and Sjögren's syndrome. Am J Ophthalmol (1988) 1.13
Visual outcome in eight cases of Serratia marcescens keratitis. Am J Ophthalmol (1981) 1.13
Scleral patch graft in the management of necrotizing scleritis. Int Ophthalmol Clin (1999) 1.13
Genetic studies on murine susceptibility to herpes simplex keratitis. Clin Immunol Immunopathol (1986) 1.13
In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver (1997) 1.13
Conjunctival lymphoma masquerading as chronic conjunctivitis. Ophthalmology (1999) 1.12
Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis. Am J Ophthalmol (1994) 1.12
The immunopathology of Mooren's ulcer. Am J Ophthalmol (1979) 1.12
Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology (1998) 1.11
Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells. Cancer Res (2001) 1.11
Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation. Exp Eye Res (2005) 1.11
Immunoglobulin deposition in localized conjunctival amyloidosis. Am J Ophthalmol (1984) 1.11
Scleritis associated with rheumatoid arthritis and with other systemic immune-mediated diseases. Ophthalmology (1994) 1.09
Secondary glaucoma in patients with uveitis. Ophthalmologica (1999) 1.09
Choroidopathy of systemic lupus erythematosus. Lupus (2000) 1.08
Predictive factors in prostate cancer: current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer. Semin Urol Oncol (1999) 1.08
Peripheral ulcerative keratitis and malignancies. Cornea (1994) 1.07
Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers. Br J Cancer (2004) 1.07
Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease. Ophthalmology (1996) 1.06
Chronic intrahepatic cholestasis in sickle cell disease requiring exchange transfusion. Gut (1995) 1.06